0.009808
0.000000
0.000000
0.000000
0.009808
0.000000
0.000000
0.000000
0.026633
0.00000
0.00000
0.00000
Czabotar, P.E.
Westphal, D.
Adams, J.M.
Colman, P.M.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
8
90.00
90.00
90.00
101.962
101.962
37.548
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
H2 O
18.015
WATER
non-polymer
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Cell(Cambridge,Mass.)
CELLB5
0998
0092-8674
152
519
10.1016/J.CELL.2012.12.031
23374347
Bax Crystal Structures Reveal How Bh3 Domains Activate Bax and Nucleate its Oligomerization to Induce Apoptosis.
2013
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
100
1
CCD
2011-12-05
ADXV
SI(111)
SINGLE WAVELENGTH
M
x-ray
1
0.9537
1.0
MX2
Australian Synchrotron
0.9537
SYNCHROTRON
AUSTRALIAN SYNCHROTRON BEAMLINE MX2
19182.711
APOPTOSIS REGULATOR BAX
RESIDUES 1-171
YES
1
man
polymer
3693.111
BH3-INTERACTING DOMAIN DEATH AGONIST
RESIDUES 76-109
1
syn
polymer
18.015
water
72
nat
water
BAX, BCL-2-LIKE PROTEIN 4, BCL2-L-4
BIDBH3, P22 BID, BID, BH3-INTERACTING DOMAIN DEATH AGONIST P P15 BID, BH3-INTERACTING DOMAIN DEATH AGONIST P13, P13 BID, BH3-INTERACTING DOMAIN DEATH AGONIST P11, P11 BID
no
no
MDGSGEQPRGGGPTSSEQIMKTGALLLQGFIQDRAGRMGGEAPELALDPVPQDASTKKLSESLKRIGDELDSNMELQRMI
AAVDTDSPREVFFRVAADMFSDGNFNWGRVVALFYFASKLVLKALSTKVPELIRTIMGWTLDFLRERLLGWIQDQGGWDG
LLSYFGTPTWQGSS
MDGSGEQPRGGGPTSSEQIMKTGALLLQGFIQDRAGRMGGEAPELALDPVPQDASTKKLSESLKRIGDELDSNMELQRMI
AAVDTDSPREVFFRVAADMFSDGNFNWGRVVALFYFASKLVLKALSTKVPELIRTIMGWTLDFLRERLLGWIQDQGGWDG
LLSYFGTPTWQGSS
A
polypeptide(L)
no
no
SESQEDIIRNIARHLAQVGDSMDRSIPPGLVNGL
SESQEDIIRNIARHLAQVGDSMDRSIPPGLVNGL
C
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
HUMAN
sample
9606
HOMO SAPIENS
562
ESCHERICHIA COLI
1
2.13
42.3
NONE
1.4 M SODIUM CITRATE, 0.1 M SODIUM CACODYLATE PH 5.75
repository
Initial release
1
0
2013-02-13
BAX DOMAIN SWAPPED DIMER IN COMPLEX WITH BAXBH3
BAX DOMAIN SWAPPED DIMER INDUCED BY OCTYLMALTOSIDE
BAX DOMAIN SWAPPED DIMER INDUCED BY BIMBH3 WITH CHAPS
BAX BH3-IN-GROOVE DIMER (GFP)
PDBE
Y
PDBE
2012-10-04
REL
HOH
water
9606
HUMAN
HOMO SAPIENS
sample
HOH
2001
3
HOH
HOH
2001
A
HOH
2002
3
HOH
HOH
2002
A
HOH
2003
3
HOH
HOH
2003
A
HOH
2004
3
HOH
HOH
2004
A
HOH
2005
3
HOH
HOH
2005
A
HOH
2006
3
HOH
HOH
2006
A
HOH
2007
3
HOH
HOH
2007
A
HOH
2008
3
HOH
HOH
2008
A
HOH
2009
3
HOH
HOH
2009
A
HOH
2010
3
HOH
HOH
2010
A
HOH
2011
3
HOH
HOH
2011
A
HOH
2012
3
HOH
HOH
2012
A
HOH
2013
3
HOH
HOH
2013
A
HOH
2014
3
HOH
HOH
2014
A
HOH
2015
3
HOH
HOH
2015
A
HOH
2016
3
HOH
HOH
2016
A
HOH
2017
3
HOH
HOH
2017
A
HOH
2018
3
HOH
HOH
2018
A
HOH
2019
3
HOH
HOH
2019
A
HOH
2020
3
HOH
HOH
2020
A
HOH
2021
3
HOH
HOH
2021
A
HOH
2022
3
HOH
HOH
2022
A
HOH
2023
3
HOH
HOH
2023
A
HOH
2024
3
HOH
HOH
2024
A
HOH
2025
3
HOH
HOH
2025
A
HOH
2026
3
HOH
HOH
2026
A
HOH
2027
3
HOH
HOH
2027
A
HOH
2028
3
HOH
HOH
2028
A
HOH
2029
3
HOH
HOH
2029
A
HOH
2030
3
HOH
HOH
2030
A
HOH
2031
3
HOH
HOH
2031
A
HOH
2032
3
HOH
HOH
2032
A
HOH
2033
3
HOH
HOH
2033
A
HOH
2034
3
HOH
HOH
2034
A
HOH
2035
3
HOH
HOH
2035
A
HOH
2036
3
HOH
HOH
2036
A
HOH
2037
3
HOH
HOH
2037
A
HOH
2038
3
HOH
HOH
2038
A
HOH
2039
3
HOH
HOH
2039
A
HOH
2040
3
HOH
HOH
2040
A
HOH
2041
3
HOH
HOH
2041
A
HOH
2042
3
HOH
HOH
2042
A
HOH
2043
3
HOH
HOH
2043
A
HOH
2044
3
HOH
HOH
2044
A
HOH
2045
3
HOH
HOH
2045
A
HOH
2046
3
HOH
HOH
2046
A
HOH
2047
3
HOH
HOH
2047
A
HOH
2048
3
HOH
HOH
2048
A
HOH
2049
3
HOH
HOH
2049
A
HOH
2050
3
HOH
HOH
2050
A
HOH
2051
3
HOH
HOH
2051
A
HOH
2052
3
HOH
HOH
2052
A
HOH
2053
3
HOH
HOH
2053
A
HOH
2054
3
HOH
HOH
2054
A
HOH
2055
3
HOH
HOH
2055
A
HOH
2056
3
HOH
HOH
2056
A
HOH
2057
3
HOH
HOH
2057
A
HOH
2058
3
HOH
HOH
2058
A
HOH
2059
3
HOH
HOH
2059
A
HOH
2060
3
HOH
HOH
2060
A
HOH
2061
3
HOH
HOH
2061
A
HOH
2062
3
HOH
HOH
2062
A
HOH
2063
3
HOH
HOH
2063
A
HOH
2064
3
HOH
HOH
2064
A
HOH
2065
3
HOH
HOH
2065
A
HOH
2066
3
HOH
HOH
2066
A
HOH
2067
3
HOH
HOH
2067
A
HOH
2068
3
HOH
HOH
2068
A
HOH
2069
3
HOH
HOH
2069
A
HOH
2001
3
HOH
HOH
2001
C
HOH
2002
3
HOH
HOH
2002
C
HOH
2003
3
HOH
HOH
2003
C
n
1
1
A
n
2
2
A
n
3
3
A
n
4
4
A
n
5
5
A
n
6
6
A
n
7
7
A
n
8
8
A
n
9
9
A
GLY
10
n
10
GLY
10
A
GLY
11
n
11
GLY
11
A
GLY
12
n
12
GLY
12
A
PRO
13
n
13
PRO
13
A
THR
14
n
14
THR
14
A
SER
15
n
15
SER
15
A
SER
16
n
16
SER
16
A
GLU
17
n
17
GLU
17
A
GLN
18
n
18
GLN
18
A
ILE
19
n
19
ILE
19
A
MET
20
n
20
MET
20
A
LYS
21
n
21
LYS
21
A
THR
22
n
22
THR
22
A
GLY
23
n
23
GLY
23
A
ALA
24
n
24
ALA
24
A
LEU
25
n
25
LEU
25
A
LEU
26
n
26
LEU
26
A
LEU
27
n
27
LEU
27
A
GLN
28
n
28
GLN
28
A
GLY
29
n
29
GLY
29
A
PHE
30
n
30
PHE
30
A
ILE
31
n
31
ILE
31
A
GLN
32
n
32
GLN
32
A
ASP
33
n
33
ASP
33
A
ARG
34
n
34
ARG
34
A
ALA
35
n
35
ALA
35
A
GLY
36
n
36
GLY
36
A
ARG
37
n
37
ARG
37
A
n
38
38
A
n
39
39
A
n
40
40
A
n
41
41
A
n
42
42
A
n
43
43
A
n
44
44
A
n
45
45
A
n
46
46
A
n
47
47
A
n
48
48
A
PRO
49
n
49
PRO
49
A
VAL
50
n
50
VAL
50
A
PRO
51
n
51
PRO
51
A
GLN
52
n
52
GLN
52
A
ASP
53
n
53
ASP
53
A
ALA
54
n
54
ALA
54
A
SER
55
n
55
SER
55
A
THR
56
n
56
THR
56
A
LYS
57
n
57
LYS
57
A
LYS
58
n
58
LYS
58
A
LEU
59
n
59
LEU
59
A
SER
60
n
60
SER
60
A
GLU
61
n
61
GLU
61
A
SER
62
n
62
SER
62
A
LEU
63
n
63
LEU
63
A
LYS
64
n
64
LYS
64
A
ARG
65
n
65
ARG
65
A
ILE
66
n
66
ILE
66
A
GLY
67
n
67
GLY
67
A
ASP
68
n
68
ASP
68
A
GLU
69
n
69
GLU
69
A
LEU
70
n
70
LEU
70
A
ASP
71
n
71
ASP
71
A
SER
72
n
72
SER
72
A
ASN
73
n
73
ASN
73
A
MET
74
n
74
MET
74
A
GLU
75
n
75
GLU
75
A
LEU
76
n
76
LEU
76
A
GLN
77
n
77
GLN
77
A
ARG
78
n
78
ARG
78
A
MET
79
n
79
MET
79
A
ILE
80
n
80
ILE
80
A
ALA
81
n
81
ALA
81
A
ALA
82
n
82
ALA
82
A
VAL
83
n
83
VAL
83
A
ASP
84
n
84
ASP
84
A
THR
85
n
85
THR
85
A
ASP
86
n
86
ASP
86
A
SER
87
n
87
SER
87
A
PRO
88
n
88
PRO
88
A
ARG
89
n
89
ARG
89
A
GLU
90
n
90
GLU
90
A
VAL
91
n
91
VAL
91
A
PHE
92
n
92
PHE
92
A
PHE
93
n
93
PHE
93
A
ARG
94
n
94
ARG
94
A
VAL
95
n
95
VAL
95
A
ALA
96
n
96
ALA
96
A
ALA
97
n
97
ALA
97
A
ASP
98
n
98
ASP
98
A
MET
99
n
99
MET
99
A
PHE
100
n
100
PHE
100
A
SER
101
n
101
SER
101
A
ASP
102
n
102
ASP
102
A
GLY
103
n
103
GLY
103
A
ASN
104
n
104
ASN
104
A
PHE
105
n
105
PHE
105
A
ASN
106
n
106
ASN
106
A
TRP
107
n
107
TRP
107
A
GLY
108
n
108
GLY
108
A
ARG
109
n
109
ARG
109
A
VAL
110
n
110
VAL
110
A
VAL
111
n
111
VAL
111
A
ALA
112
n
112
ALA
112
A
LEU
113
n
113
LEU
113
A
PHE
114
n
114
PHE
114
A
TYR
115
n
115
TYR
115
A
PHE
116
n
116
PHE
116
A
ALA
117
n
117
ALA
117
A
SER
118
n
118
SER
118
A
LYS
119
n
119
LYS
119
A
LEU
120
n
120
LEU
120
A
VAL
121
n
121
VAL
121
A
LEU
122
n
122
LEU
122
A
LYS
123
n
123
LYS
123
A
ALA
124
n
124
ALA
124
A
LEU
125
n
125
LEU
125
A
SER
126
n
126
SER
126
A
THR
127
n
127
THR
127
A
LYS
128
n
128
LYS
128
A
VAL
129
n
129
VAL
129
A
PRO
130
n
130
PRO
130
A
GLU
131
n
131
GLU
131
A
LEU
132
n
132
LEU
132
A
ILE
133
n
133
ILE
133
A
ARG
134
n
134
ARG
134
A
THR
135
n
135
THR
135
A
ILE
136
n
136
ILE
136
A
MET
137
n
137
MET
137
A
GLY
138
n
138
GLY
138
A
TRP
139
n
139
TRP
139
A
THR
140
n
140
THR
140
A
LEU
141
n
141
LEU
141
A
ASP
142
n
142
ASP
142
A
PHE
143
n
143
PHE
143
A
LEU
144
n
144
LEU
144
A
ARG
145
n
145
ARG
145
A
GLU
146
n
146
GLU
146
A
ARG
147
n
147
ARG
147
A
LEU
148
n
148
LEU
148
A
LEU
149
n
149
LEU
149
A
GLY
150
n
150
GLY
150
A
TRP
151
n
151
TRP
151
A
ILE
152
n
152
ILE
152
A
GLN
153
n
153
GLN
153
A
ASP
154
n
154
ASP
154
A
GLN
155
n
155
GLN
155
A
GLY
156
n
156
GLY
156
A
GLY
157
n
157
GLY
157
A
TRP
158
n
158
TRP
158
A
ASP
159
n
159
ASP
159
A
GLY
160
n
160
GLY
160
A
LEU
161
n
161
LEU
161
A
LEU
162
n
162
LEU
162
A
SER
163
n
163
SER
163
A
TYR
164
n
164
TYR
164
A
PHE
165
n
165
PHE
165
A
GLY
166
n
166
GLY
166
A
THR
167
n
167
THR
167
A
n
168
168
A
n
169
169
A
n
170
170
A
n
171
171
A
n
172
172
A
n
173
173
A
n
174
174
A
SER
76
n
1
SER
76
C
GLU
77
n
2
GLU
77
C
SER
78
n
3
SER
78
C
GLN
79
n
4
GLN
79
C
GLU
80
n
5
GLU
80
C
ASP
81
n
6
ASP
81
C
ILE
82
n
7
ILE
82
C
ILE
83
n
8
ILE
83
C
ARG
84
n
9
ARG
84
C
ASN
85
n
10
ASN
85
C
ILE
86
n
11
ILE
86
C
ALA
87
n
12
ALA
87
C
ARG
88
n
13
ARG
88
C
HIS
89
n
14
HIS
89
C
LEU
90
n
15
LEU
90
C
ALA
91
n
16
ALA
91
C
GLN
92
n
17
GLN
92
C
VAL
93
n
18
VAL
93
C
GLY
94
n
19
GLY
94
C
ASP
95
n
20
ASP
95
C
SER
96
n
21
SER
96
C
MET
97
n
22
MET
97
C
ASP
98
n
23
ASP
98
C
ARG
99
n
24
ARG
99
C
SER
100
n
25
SER
100
C
ILE
101
n
26
ILE
101
C
PRO
102
n
27
PRO
102
C
PRO
103
n
28
PRO
103
C
GLY
104
n
29
GLY
104
C
LEU
105
n
30
LEU
105
C
n
31
106
C
n
32
107
C
n
33
108
C
n
34
109
C
0.9404
0.7919
-0.2135
0.9020
-0.0499
-0.0819
-0.0219
0.0928
0.1052
-0.0677
0.0649
0.0988
0.0408
-0.0095
0.0094
0.1821
-0.0289
0.0004
0.2134
0.0608
0.1700
refined
18.9614
-8.1719
41.7997
X-RAY DIFFRACTION
X-RAY DIFFRACTION
1
ALL
author_and_software_defined_assembly
PISA
4
tetrameric
11300
-124.8
16870
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
0.0000000000
-1.0000000000
0.0000000000
-1.0000000000
0.0000000000
0.0000000000
0.0000000000
0.0000000000
-1.0000000000
8_557
-y,-x,-z+5/2
crystal symmetry operation
0.0000000000
0.0000000000
93.8700000000
1
C
HOH
2003
D
HOH
1
A
MET
1
A
MET
1
1
Y
1
A
ASP
2
A
ASP
2
1
Y
1
A
GLY
3
A
GLY
3
1
Y
1
A
SER
4
A
SER
4
1
Y
1
A
GLY
5
A
GLY
5
1
Y
1
A
GLU
6
A
GLU
6
1
Y
1
A
GLN
7
A
GLN
7
1
Y
1
A
PRO
8
A
PRO
8
1
Y
1
A
ARG
9
A
ARG
9
1
Y
1
A
MET
38
A
MET
38
1
Y
1
A
GLY
39
A
GLY
39
1
Y
1
A
GLY
40
A
GLY
40
1
Y
1
A
GLU
41
A
GLU
41
1
Y
1
A
ALA
42
A
ALA
42
1
Y
1
A
PRO
43
A
PRO
43
1
Y
1
A
GLU
44
A
GLU
44
1
Y
1
A
LEU
45
A
LEU
45
1
Y
1
A
ALA
46
A
ALA
46
1
Y
1
A
LEU
47
A
LEU
47
1
Y
1
A
ASP
48
A
ASP
48
1
Y
1
A
PRO
168
A
PRO
168
1
Y
1
A
THR
169
A
THR
169
1
Y
1
A
TRP
170
A
TRP
170
1
Y
1
A
GLN
171
A
GLN
171
1
Y
1
A
GLY
172
A
GLY
172
1
Y
1
A
SER
173
A
SER
173
1
Y
1
A
SER
174
A
SER
174
1
Y
1
C
VAL
106
B
VAL
31
1
Y
1
C
ASN
107
B
ASN
32
1
Y
1
C
GLY
108
B
GLY
33
1
Y
1
C
LEU
109
B
LEU
34
1
Y
1
A
A
O
O
HOH
HOH
2049
2050
2.08
1
A
A
O
O
THR
HOH
167
2068
2.14
1
A
A
NE
O
ARG
HOH
34
2011
2.18
1
A
A
O
O
HOH
HOH
2017
2062
2.16
1_555
8_557
1
A
ASN
73
-65.21
98.98
1
A
SER
87
-116.73
69.14
41.17
0.7605
0.0000
0.0000
0.7605
0.0000
-1.5210
0.2270
0.1763
0.1790
2.206
50.981
522
10428
5.0
99.78
0.32
1
2.00
MOLECULAR REPLACEMENT
21.97
0.86
1.10
BAX DOMAIN SWAPPED DIMER INDUCED BY OCTYLMALTOSIDE
ML
FLAT BULK SOLVENT MODEL
61.640
0.376
2.206
50.981
72
1455
0
0
1383
0.008
1407
0.973
1894
14.018
524
0.064
208
0.004
245
0.3313
0.2437
2.4280
126
2388
99.00
0.2724
0.2023
2.7793
128
2438
100.00
0.2579
0.1788
3.5015
130
2474
100.00
0.1771
0.1529
50.9946
138
2606
100.00
34.53
2.21
51.00
4BD2
10428
-3.0
0.22
1
9.66
13.9
99.8
1.50
2.21
2.43
2.02
1
14.1
98.8
refinement
PHENIX
(PHENIX.REFINE)
data reduction
XDS
data scaling
XDS
phasing
PHASER
APOPTOSIS REGULATOR BAX, BH3-INTERACTING DOMAIN DEATH AGONIST
Bax domain swapped dimer in complex with BidBH3
1
N
N
2
N
N
3
N
N
3
N
N
A
SER
15
A
SER
15
HELX_P
A
ARG
37
A
ARG
37
1
1
23
A
ASP
53
A
ASP
53
HELX_P
A
ASN
73
A
ASN
73
1
2
21
A
ASN
73
A
ASN
73
HELX_P
A
VAL
83
A
VAL
83
1
3
11
A
SER
87
A
SER
87
HELX_P
A
PHE
100
A
PHE
100
1
4
14
A
ASN
106
A
ASN
106
HELX_P
A
LEU
148
A
LEU
148
1
5
43
A
LEU
148
A
LEU
148
HELX_P
A
GLN
155
A
GLN
155
1
6
8
A
TRP
158
A
TRP
158
HELX_P
A
PHE
165
A
PHE
165
1
7
8
C
SER
76
B
SER
1
HELX_P
C
MET
97
B
MET
22
1
8
22
C
ASP
98
B
ASP
23
HELX_P
C
SER
100
B
SER
25
5
9
3
APOPTOSIS
APOPTOSIS, PROGRAMMED CELL DEATH, BCL-2 FAMILY.
C
ILE
101
B
ILE
26
1
C
PRO
102
B
PRO
27
0.62
BAX_HUMAN
UNP
1
Q07812
BID_HUMAN
UNP
2
P55957
1
171
4BD2
1
171
Q07812
A
1
1
171
76
109
4BD2
76
109
P55957
C
2
1
34
1
expression tag
GLY
172
4BD2
A
Q07812
UNP
172
1
expression tag
SER
173
4BD2
A
Q07812
UNP
173
1
expression tag
SER
174
4BD2
A
Q07812
UNP
174
1
CYS
engineered mutation
SER
62
4BD2
A
Q07812
UNP
62
62
1
CYS
engineered mutation
SER
126
4BD2
A
Q07812
UNP
126
126
96
P 43 21 2